# Electrocardiogram Clinical Validation Study

Study · id `cardio:ct-nct03492554` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03492554](<https://clinicaltrials.gov/study/NCT03492554>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03492554

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 602 participants.

## Technical summary

Registry record NCT03492554. Non-randomized; no masking; primary purpose basic science. Start 2018-03-12 (actual); primary completion 2018-05-14 (actual). Results posted on 2019-07-24.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose basic science
- Phase: Not applicable
- Enrolled: 602 participants (enrolled count; ClinicalTrials.gov record NCT03492554, source copy `cardio:ctgov-nct03492554-2020-12-03`, retrieved 2026-10-26)
- Started: 2018-03-12 (actual) (ClinicalTrials.gov record NCT03492554, source copy `cardio:ctgov-nct03492554-2020-12-03`, retrieved 2026-10-26)
- Primary completion: 2018-05-14 (actual) (ClinicalTrials.gov record NCT03492554, source copy `cardio:ctgov-nct03492554-2020-12-03`, retrieved 2026-10-26)
- Completion: 2018-05-14 (actual) (ClinicalTrials.gov record NCT03492554, source copy `cardio:ctgov-nct03492554-2020-12-03`, retrieved 2026-10-26)
- Results first posted: 2019-07-24 (ClinicalTrials.gov record NCT03492554, source copy `cardio:ctgov-nct03492554-2020-12-03`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03492554, source copy `cardio:ctgov-nct03492554-2020-12-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03492554-2020-12-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Electrocardiogram Clinical Validation Study
- Condition: Atrial Fibrillation
- Intervention (Other): 1-Lead ECG
- Intervention (Device): 12-Lead ECG
- Lead sponsor: Apple Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: IQVIA Pty Ltd
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Apple (`cardio:apple`)
- Registry lists this organization as a collaborator: IQVIA Pty Ltd (`cardio:org-iqvia-pty-ltd`)

## Provenance

Content hash: 5573ce632317cf78b66948bdf44c07c292c1e2a5735c2c0e989b5a0ef0c5ddae
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
